AgomAb Therapeutics NV

AGMB

Börsenwert 408 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 EQT Fund Management Luxembourg	66,7 Mio. $	–	–	–
2	S 2 Sanofi Paris, France	36,1 Mio. $	–	–	–
3	3 Redmile Group San Francisco, California	35,5 Mio. $	+29 Mio. $	+2.577.676	+1.650 %
4	4 Cormorant Asset Management Boston, Massachusetts	32 Mio. $	–	–	–
5	5 TCG Crossover Management Palo Alto, California	26,7 Mio. $	–	–	–
6	6 Federated Hermes Pittsburgh, Pennsylvania	21 Mio. $	–	–	–
7	7 Nantahala Capital Management New Canaan, Connecticut	20,4 Mio. $	+4,14 Mio. $	+368.188	+31 %
8	8 Casdin Capital New York	20,1 Mio. $	–	–	–
9	AP 9 Andera Partners Paris,	20 Mio. $	–	–	–
10	10 Fidelity Investments Boston, Massachusetts	18,9 Mio. $	–	–	–
11	11 Aberdeen Group Edinburgh, United Kingdom	11 Mio. $	+1,57 Mio. $	+139.039	+20 %
12	12 Perceptive Advisors New York	7,79 Mio. $	–	–	–
13	13 Samsara BioCapital Palo Alto, California	7,79 Mio. $	–	–	–
14	SL 14 Siren LLC Greenwich, Connecticut	5,34 Mio. $	–	–	–
15	15 OrbiMed New York	2,5 Mio. $	+2,17 Mio. $	+192.740	Neu
16	P 16 Pfizer New York	1,04 Mio. $	–	–	–
17	17 ALPS Advisors Denver, Colorado	648.792 $	+562.625 $	+49.984	Neu
18	18 Bellevue Group Kuesnacht, Switzerland	639.239 $	-8.465 $	-752	-2 %
19	19 Seven Grand Managers Bronxville, New York	617.848 $	-1,72 Mio. $	-152.400	-76 %
20	SAM 20 Sectoral Asset Management Montreal, Quebec, Canada	564.630 $	–	–	–
21	21 Burkehill Global Management New York	454.300 $	–	–	–
22	22 Quadrature Capital London, United Kingdom	265.584 $	+230.311 $	+20.461	Neu
23	23 Two Sigma Investments New York	234.575 $	+43.122 $	+3.831	+27 %
24	24 HRT Financial New York	221.000 $	-74.864 $	-6.651	-28 %
25	25 Goldman Sachs New York	153.164 $	-269.460 $	-23.939	-67 %

AgomAb Therapeutics NV AGMB Börsenwert 408 Mio. $

AgomAb Therapeutics NV

AGMB

Börsenwert 408 Mio. $